LIXTE Biotechnology Provides Update on Clinical Progress and

PASADENA, Calif., Nov. 13, 2023 (GLOBE NEWSWIRE) -- LIXTE Biotechnology Holdings, Inc. (“LIXTE” or the “Company”) (Nasdaq: LIXT and LIXTW), a cl...

Related Keywords

Netherlands , United States , Johns Kovach , Flaurie Berman , Company Nasdaq , Loncode Institute , Netherlands Cancer Institute , Biotechnology Holdings Inc , Securities Exchange , Spanish Sarcoma Group Grupo Espa , Linkedin , Company Quarterly Report On Form , Exchange Commission , Md Anderson Cancer Center , Sarah Cannon Research Institute , Pondelwilkinson Inc , Twitter , University Of Texas , Cancer Center , Northwestern University , Comprehensive Cancer , Spanish Sarcoma Group , Grupo Espa , Cannon Research Institute , Chief Executive Officer , Quarterly Report , United States Securities , Securities Act , Securities Exchange Act , Investor Relations ,